Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Pocius, Kristina
DOB: 20-JAN-1944 (Age: 82)
Gender: male
Address:
99218 Nagys Ridge
93234 West Marijaside (Lithuania)
ID: 5121-608381-9 (ECI)
Report
Date: 02-FEB-2019
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Dr. Tomas Bakas
182 Savanorių pr.
LT-91200 Klaipėda (Lithuania)
Specimen
Collected: 02-FEB-2019

Chemistry

Test 02-FEB-2019 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 83.5 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 7.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 8.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 136.0 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.9 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 108.8 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.7 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 134.9 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 114.2 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 83.7 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 28.3 L 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 8.5 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Laboratory results are largely within normal limits, indicating good glycemic, renal, and metabolic control. Notable findings include mildly elevated chloride and low HDL cholesterol, which may increase cardiovascular risk. Continued monitoring of lipid profile and cardiovascular risk factors is recommended. No evidence of renal dysfunction or significant metabolic derangement at this time.